A virus does not become a pandemic simply because it kills.
When the MV Hondius docked carrying nine cases of Andes virus, the shadow of the Ruby Princess fell immediately across public memory — and with it, the fear that history might repeat itself. Three people have died, and six passengers from Australia and New Zealand are now in quarantine near Perth. But the experts who study how viruses move through populations are asking us to hold two truths at once: that this illness is genuinely deadly, and that the conditions required for it to become something larger simply do not exist in the way they did for COVID.
- Three deaths and nine confirmed or probable cases linked to a single cruise ship have reignited pandemic anxiety still raw from COVID's global devastation.
- The comparison to the Ruby Princess is emotionally immediate but scientifically misleading — Andes virus needs close contact, poor ventilation, and symptomatic carriers to spread, conditions the general world does not offer it.
- A 42-day incubation window and a fatality rate reaching 50% in severe cases make containment both urgent and medically demanding, with no approved antiviral or vaccine available.
- Swiss laboratories sequenced the virus's full genome within days of the outbreak, giving public health teams worldwide the tools to confirm cases, trace links, and isolate those at risk.
- Quarantined passengers face weeks of monitoring and layered testing, because early negative results cannot rule out a virus still quietly incubating in the body.
When the MV Hondius docked with nine Andes virus cases aboard — seven confirmed, two probable — the comparison to COVID was immediate. Six years earlier, the Ruby Princess had arrived in Sydney carrying 575 COVID cases and a catastrophe. Three people have now died from this outbreak. Five Australians and one New Zealander are quarantined at a facility near RAAF Base Pearce in Western Australia. The fear is real. The parallel, experts say, is not.
Andes virus is a rodent-borne hantavirus, unusual among its family for being the only member known to spread reliably between people. But that reliability has limits. Where SARS-CoV-2 moves through the air with brutal efficiency and can infect others before a carrier even feels sick, Andes virus requires close contact, crowded spaces, poor ventilation, and time. The MV Hondius provided exactly that environment. The general population does not.
The virus also progresses slowly. The WHO recommends 42 days of monitoring after potential exposure — a window that reflects how differently this pathogen behaves compared to COVID, which replicates rapidly in the respiratory system within days. Severe Andes virus disease emerges not from direct lung destruction but from a delayed immune response that causes fluid to leak into the lungs. This slow-burn biology limits how quickly and widely the virus can travel.
The fatality rate is genuinely alarming — American strains can reach 50% in severe cases — and there is no specific antiviral drug or licensed vaccine. Treatment means close monitoring, respiratory support, and managing complications. But what has moved fast is the science: Swiss laboratories sequenced the virus's complete genome from a single patient and published it within days, giving researchers worldwide a reference point to confirm cases and map outbreak links.
Andes virus is dangerous. Authorities are right to respond carefully. But it lacks what made COVID catastrophic: efficient airborne spread, rapid replication, and transmission from people who don't yet know they're sick. Getting this outbreak under control matters. Treating it as the next pandemic does not.
When the MV Hondius docked and nine cases of Andes virus emerged—seven confirmed, two probable—the reflexive comparison to COVID was immediate and understandable. Six years earlier, the Ruby Princess had arrived in Sydney with 575 COVID cases aboard, and the virus had spilled into the community with devastating speed. Three people have now died from Andes virus linked to this cruise ship. Five Australians and one New Zealander are being quarantined at the Centre for National Resilience near RAAF Base Pearce in Western Australia. The fear is real. But the parallel, experts say, is misleading.
Andes virus is a rodent-borne hantavirus, typically transmitted when people inhale particles from infected rodent urine, droppings, or saliva. What makes it unusual among hantaviruses is that it can spread from person to person—the only member of its family known to do so reliably. But "reliably" is a relative term. Unlike SARS-CoV-2, which moves through the air with brutal efficiency and can infect others before a person even knows they're sick, Andes virus requires a specific set of conditions to jump between humans. It needs close contact, crowded spaces, poor ventilation, and time. The MV Hondius provided exactly that. In the general population, it does not.
The difference in transmission mechanics is fundamental. Early estimates suggested each person infected with COVID passed the virus to roughly two or more others on average in naive populations. Andes virus, by contrast, spreads only in what epidemiologists call a perfect storm—symptomatic people in enclosed spaces with sustained close contact. This is why COVID became a pandemic and Andes virus has only produced contained outbreaks, even when deadly.
The virus itself progresses slowly. The World Health Organization recommends monitoring exposed people for 42 days after potential contact, reflecting the outer limit of incubation. COVID symptoms typically appear within days because the virus replicates rapidly in the respiratory system. Andes virus works differently. Severe disease emerges from blood-vessel dysfunction and the immune system's delayed inflammatory response. The breathing problems of hantavirus pulmonary syndrome—the life-threatening complication—aren't caused by the virus directly destroying lung tissue but by fluid leaking into the lungs as the body's defenses finally mobilize. This slow-burn progression limits how quickly and widely the virus can spread.
The fatality rate is genuinely alarming. American strains of hantavirus, including Andes, can reach 50% mortality in severe cases, compared to less than 15% for European and Asian variants. In 2025, eight countries across the Americas reported 229 hantavirus cases and 59 deaths. These are serious infections. But they remain rare events, and they remain contained. There is no specific antiviral drug for Andes virus and no licensed vaccine. Treatment focuses on close monitoring, respiratory support, and managing complications to the heart and kidneys.
What has moved quickly is the scientific response. Swiss laboratories sequenced the complete genetic code of the virus from one patient and made it publicly available within days. This gave researchers worldwide a reference point to compare other cases, enabling faster confirmation of suspected infections and helping public health teams identify outbreak links and determine who needs isolation or monitoring. The machinery of modern epidemiology, in other words, is already engaged.
The returning passengers will spend three weeks in initial quarantine, with further monitoring to follow. Testing will use PCR to detect viral genetic material and serology to identify antibody responses. A negative test early after exposure is useful but not definitive—the virus may still be incubating, with insufficient genetic material or antibody response to detect. This is why the 42-day window exists.
A virus does not become a pandemic simply because it kills. Andes virus is dangerous to those infected, and authorities are right to respond cautiously. But it lacks the characteristics that made COVID a global catastrophe: efficient airborne transmission, rapid replication, and the ability to spread from asymptomatic carriers. It incubates slowly, typically spreads through close contact, and transmits most efficiently when people are already symptomatic and aware they're sick. Getting Andes virus under control matters. Treating it as a pandemic threat does not.
Citas Notables
Andes virus can cause onward human-to-human transmission, but requires a perfect storm of conditions: symptomatic people in crowded, poorly ventilated spaces with close contact over time.— World Health Organization and health experts cited in analysis
La Conversación del Hearth Otra perspectiva de la historia
Why does a virus with a 50% fatality rate not worry epidemiologists the way COVID did?
Because deadliness and transmissibility are different things. A virus that kills half its victims but only spreads in households and poorly ventilated rooms stays contained. A virus that kills 1% but spreads through the air before you know you're sick becomes a pandemic. Andes virus is the first problem; COVID was the second.
So the cruise ship was actually the worst-case scenario for this virus?
Exactly. Crowded ship, recycled air, people in close quarters for days. That's the perfect storm Andes needs. In normal life—in communities, in cities—those conditions don't exist. The virus can't replicate its way out of a household the way COVID could.
The 42-day monitoring period sounds long. Does that mean people are contagious for six weeks?
No. That's the outer limit for symptoms to appear. It doesn't mean you're infectious for 42 days. Once you're symptomatic, you're actually easier to isolate because you know you're sick. COVID's trick was infecting people before they had any idea.
Why did it take Swiss labs days to sequence the virus, but we're still waiting for treatments?
Sequencing is reading the instruction manual. Treatment is building a drug that works against it. One is information; the other is chemistry and testing. The sequencing helps us identify cases faster and track the outbreak. That's valuable. But it doesn't cure the infection.
If there's no vaccine and no antiviral, what actually saves people?
Time and support. Your own immune system eventually fights it off, if your lungs don't fill with fluid first. Doctors keep you breathing, manage your heart and kidney function, and hope your body wins the race. It's brutal medicine, but it works often enough that people survive.
What should people actually be worried about with this outbreak?
Whether the virus spreads beyond the people already exposed. If it stays contained to the cruise ship contacts and their close contacts, this becomes a footnote. If it finds its way into a community with poor healthcare or dense housing, it becomes harder to control. But the virus itself isn't the problem—our ability to isolate it is.